Imperial College London

Professor Hesham Saleh

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Practice (Rhinology)
 
 
 
//

Contact

 

+44 (0)20 3311 1025h.saleh Website

 
 
//

Location

 

Charing Cross HospitalCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Choudhury:2016:10.1017/S0022215116008483,
author = {Choudhury, N and Hariri, A and Saleh, H},
doi = {10.1017/S0022215116008483},
journal = {J Laryngol Otol},
pages = {827--832},
title = {Extended applications of the endoscopic modified Lothrop procedure.},
url = {http://dx.doi.org/10.1017/S0022215116008483},
volume = {130},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - OBJECTIVE: The endoscopic modified Lothrop procedure is mainly used for refractory frontal sinusitis. However, we have used it as an access procedure to facilitate treatment for an extended range of additional frontal sinus pathologies. METHODS: A retrospective review of patients who underwent the endoscopic modified Lothrop procedure for 'alternative' frontal sinus pathologies was conducted. Patient data were reviewed. The main outcome parameter measured was signs of recurrence. RESULTS: Twelve patients (6 males, 6 females) from a 7-year study period, with a mean age of 45.2 years (range, 16-78 years), were analysed. The surgical indications included frontoethmoidal mucoceles, cerebrospinal fluid leaks within the frontal sinus, cystic fibrosis, frontal sinus osteoma, frontal sinus ossifying fibroma and frontal silent sinus syndrome. The mean follow-up period was 33.3 months. There were no known recurrences. CONCLUSION: We have used the endoscopic modified Lothrop procedure for a range of frontal sinus pathologies, safely and effectively, with no peri-operative complications.
AU - Choudhury,N
AU - Hariri,A
AU - Saleh,H
DO - 10.1017/S0022215116008483
EP - 832
PY - 2016///
SP - 827
TI - Extended applications of the endoscopic modified Lothrop procedure.
T2 - J Laryngol Otol
UR - http://dx.doi.org/10.1017/S0022215116008483
UR - https://www.ncbi.nlm.nih.gov/pubmed/27424998
VL - 130
ER -